Dimensional Fund Advisors LP Y M Abs Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$391 Billion
Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 418,554 shares of YMAB stock, worth $2.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

418,554

Previous 463,235 9.65%

Holding current value

$2.13 Million

Previous $3.63 Million 48.88%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$4.43 - $8.17 $197,936 - $365,043	-44,681 Reduced 9.65%	418,554 $1.85 Million
Q4 2024 Feb 13, 2025	SELL	$7.76 - $15.69 $111,969 - $226,391	-14,429 Reduced 3.02%	463,235 $3.63 Million
Q3 2024 Nov 07, 2024	SELL	$9.95 - $15.39 $67,331 - $104,144	-6,767 Reduced 1.4%	477,664 $6.27 Million
Q2 2024 Aug 09, 2024	BUY	$11.6 - $17.25 $762,491 - $1.13 Million	65,732 Added 15.7%	484,431 $5.85 Million
Q1 2024 May 10, 2024	BUY	$6.57 - $18.69 $693,778 - $1.97 Million	105,598 Added 33.73%	418,699 $6.81 Million
Q4 2023 Feb 07, 2024	BUY	$4.88 - $7.42 $348,978 - $530,619	71,512 Added 29.6%	313,101 $2.14 Million
Q3 2023 Nov 09, 2023	BUY	$4.86 - $7.23 $544,762 - $810,417	112,091 Added 86.56%	241,589 $1.32 Million
Q2 2023 Aug 09, 2023	BUY	$5.68 - $10.34 $113,974 - $207,482	20,066 Added 18.34%	129,498 $879,000
Q1 2023 May 12, 2023	SELL	$2.83 - $5.11 $33,122 - $59,807	-11,704 Reduced 9.66%	109,432 $548,000
Q4 2022 Feb 09, 2023	SELL	$3.0 - $15.17 $34,425 - $174,075	-11,475 Reduced 8.65%	121,136 $591,000
Q3 2022 Nov 10, 2022	SELL	$13.96 - $19.67 $1.22 Million - $1.72 Million	-87,356 Reduced 39.71%	132,611 $1.91 Million
Q2 2022 Aug 12, 2022	BUY	$8.22 - $15.13 $300,843 - $553,742	36,599 Added 19.96%	219,967 $3.33 Million
Q1 2022 May 13, 2022	SELL	$6.55 - $17.42 $55,242 - $146,920	-8,434 Reduced 4.4%	183,368 $2.18 Million
Q4 2021 Feb 09, 2022	BUY	$15.51 - $29.31 $1.03 Million - $1.94 Million	66,280 Added 52.8%	191,802 $3.11 Million
Q3 2021 Nov 12, 2021	BUY	$27.47 - $37.31 $3.45 Million - $4.68 Million	125,522 New	125,522 $3.58 Million

Others Institutions Holding YMAB

# of Institutions

105

Shares Held

27.1M

Call Options Held

38.4K

Put Options Held

2.1K

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $223M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Y M Abs Therapeutics, Inc. Transaction History